These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 10417777

  • 1. Effect of a chimeric anti-ganglioside GM2 antibody on ganglioside GM2-expressing human solid tumors in vivo.
    Fukumoto H, Nishio K, Ohta S, Hanai N, Fukuoka K, Ohe Y, Sugihara K, Kodama T, Saijo N.
    Int J Cancer; 1999 Aug 27; 82(5):759-64. PubMed ID: 10417777
    [Abstract] [Full Text] [Related]

  • 2. Reversal of adriamycin resistance with chimeric anti-ganglioside GM2 antibody.
    Fukumoto H, Nishio K, Ohta S, Hanai N, Saijo N.
    Int J Cancer; 1996 Sep 04; 67(5):676-80. PubMed ID: 8782657
    [Abstract] [Full Text] [Related]

  • 3. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
    Nakamura K, Koike M, Shitara K, Kuwana Y, Kiuragi K, Igarashi S, Hasegawa M, Hanai N.
    Cancer Res; 1994 Mar 15; 54(6):1511-6. PubMed ID: 8137257
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic efficacy of mouse-human chimeric anti-ganglioside GM2 monoclonal antibody against multiple organ micrometastases of human lung cancer in NK cell-depleted SCID mice.
    Hanibuchi M, Yano S, Nishioka Y, Yanagawa H, Kawano T, Sone S.
    Int J Cancer; 1998 Nov 09; 78(4):480-5. PubMed ID: 9797137
    [Abstract] [Full Text] [Related]

  • 5. Immunological circumvention of multiple organ metastases of multidrug resistant human small cell lung cancer cells by mouse-human chimeric anti-ganglioside GM2 antibody KM966.
    Hanibuchi M, Yano S, Nishioka Y, Yanagawa H, Miki T, Sone S.
    Clin Exp Metastasis; 2000 Nov 09; 18(5):353-60. PubMed ID: 11467766
    [Abstract] [Full Text] [Related]

  • 6. Genetically engineered humanized anti-ganglioside GM2 antibody against multiple organ metastasis produced by GM2-expressing small-cell lung cancer cells.
    Yamada T, Bando H, Takeuchi S, Kita K, Li Q, Wang W, Akinaga S, Nishioka Y, Sone S, Yano S.
    Cancer Sci; 2011 Dec 09; 102(12):2157-63. PubMed ID: 21895875
    [Abstract] [Full Text] [Related]

  • 7. Humanized anti-ganglioside GM2 antibody is effective to induce antibody-dependent cell-mediated cytotoxicity in mononuclear cells from lung cancer patients.
    Parajuli P, Yanagawa H, Hanibuchi M, Takeuchi E, Miki T, Yano S, Sone S.
    Cancer Lett; 2001 Apr 26; 165(2):179-84. PubMed ID: 11275367
    [Abstract] [Full Text] [Related]

  • 8. Reactivity of a mouse/human chimeric anti-GM2 antibody KM966 with brain tumors.
    Dohi T, Nakamura K, Hanai N, Taomoto K, Oshima M.
    Anticancer Res; 1994 Apr 26; 14(6B):2577-81. PubMed ID: 7872684
    [Abstract] [Full Text] [Related]

  • 9. Anti-ganglioside GM2 monoclonal antibody-dependent killing of human lung cancer cells by lymphocytes and monocytes.
    Hanibuchi M, Yano S, Nishioka Y, Yanagawa H, Sone S.
    Jpn J Cancer Res; 1996 May 26; 87(5):497-504. PubMed ID: 8641987
    [Abstract] [Full Text] [Related]

  • 10. Dissection and optimization of immune effector functions of humanized anti-ganglioside GM2 monoclonal antibody.
    Nakamura K, Tanaka Y, Fujino I, Hirayama N, Shitara K, Hanai N.
    Mol Immunol; 2000 Dec 26; 37(17):1035-46. PubMed ID: 11399321
    [Abstract] [Full Text] [Related]

  • 11. Recombinant antibodies against ganglioside expressed on tumor cells.
    Hanai N, Nakamura K, Shitara K.
    Cancer Chemother Pharmacol; 2000 Dec 26; 46 Suppl():S13-7. PubMed ID: 10950141
    [Abstract] [Full Text] [Related]

  • 12. Apoptosis induction of human lung cancer cell line in multicellular heterospheroids with humanized antiganglioside GM2 monoclonal antibody.
    Nakamura K, Hanibuchi M, Yano S, Tanaka Y, Fujino I, Inoue M, Takezawa T, Shitara K, Sone S, Hanai N.
    Cancer Res; 1999 Oct 15; 59(20):5323-30. PubMed ID: 10537316
    [Abstract] [Full Text] [Related]

  • 13. Human interferon-gamma enhances expression of ganglioside GM2 on human lung cancer cells and their susceptibility for antiganglioside GM2 monoclonal antibody-dependent cellular cytotoxicity.
    Hanibuchi M, Nishioka Y, Yanagawa H, Yano S, Parajuli P, Bando M, Sone S.
    Oncol Res; 2000 Oct 15; 12(4):173-9. PubMed ID: 11341466
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies.
    Ohta S, Igarashi S, Honda A, Sato S, Hanai N.
    Anticancer Res; 1993 Oct 15; 13(2):331-6. PubMed ID: 8517645
    [Abstract] [Full Text] [Related]

  • 15. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I, Komuta K, Hara H, Inoue T, Hosoe S, Ikeda T, Shirasaka T, Yokota S, Tanio Y, Masuno T.
    Cancer Res; 1988 Mar 01; 48(5):1173-9. PubMed ID: 3257715
    [Abstract] [Full Text] [Related]

  • 16. Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Camplyobacter jejuni.
    Ritter G, Fortunato SR, Cohen L, Noguchi Y, Bernard EM, Stockert E, Old LJ.
    Int J Cancer; 1996 Apr 10; 66(2):184-90. PubMed ID: 8603809
    [Abstract] [Full Text] [Related]

  • 17. Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts.
    Retter MW, Johnson JC, Peckham DW, Bannink JE, Bangur CS, Dresser K, Cai F, Foy TM, Fanger NA, Fanger GR, Woda B, Rock KL.
    Cancer Res; 2005 Jul 15; 65(14):6425-34. PubMed ID: 16024647
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneity of multiorgan metastases of human lung cancer cells genetically engineered to produce cytokines and reversal using chimeric monoclonal antibodies in natural killer cell-depleted severe combined immunodeficient mice.
    Sone S, Yano S, Hanibuchi M, Nokihara H, Nishimura N, Miki T, Nishioka Y, Shinohara T.
    Cancer Chemother Pharmacol; 1999 Jul 15; 43 Suppl():S26-31. PubMed ID: 10357555
    [Abstract] [Full Text] [Related]

  • 19. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
    Alvarez-Rueda N, Leprieur S, Clémenceau B, Supiot S, Sébille-Rivain V, Faivre-Chauvet A, Davodeau F, Paris F, Barbet J, Aubry J, Birklé S.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
    [Abstract] [Full Text] [Related]

  • 20. Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy.
    Livingston PO, Hood C, Krug LM, Warren N, Kris MG, Brezicka T, Ragupathi G.
    Cancer Immunol Immunother; 2005 Oct 15; 54(10):1018-25. PubMed ID: 15926079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.